S1 Dataset - by Anotida R. Hove (20513536)

“…The most perceived barriers and facilitators to PA were reported as exercise environment and life enhancement, respectively. Lower education (AOR 5.24 [1.69: 16.19]), multigravida (AOR .47 [.31: .42]), not exercising pre-pregnancy (AOR 2.02 [1.30: 3.13]), perceived decreased current PA level (AOR 2.04 [1.22: 3.43]) and not being advised by a doctor on exercise (AOR 2.05 [1.04: 4.04]) were associated with physical inactivity. …”

IHC examination of jejunum specimens. by Raimundo Fernandes de Araújo Júnior (429840)

IHC examination of jejunum specimens. by Raimundo Fernandes de Araújo Júnior (429840)

Percentage of the predicted <i>CYP2C19</i> (A), <i>CYP3A5</i> (B), <i>DPYD</i> (C), <i>CYP2C9</i> (D), <i>TPMT</i> (E), <i>NUDT15</i> (F) metabolizer groups. by Ewa Goljan (3463487)

Subjects:

Image_2_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

Image_3_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

Adverse events and treatment interruptions. by Nicola Squillace (691608)

“…At T1, ART-experienced PLWH showed a significant reduction of total cholesterol (TC) and triglycerides, and a slight increase in blood glucose (BG) and ALT. …”

Flow chart of the treatment interruptions. by Nicola Squillace (691608)

“…At T1, ART-experienced PLWH showed a significant reduction of total cholesterol (TC) and triglycerides, and a slight increase in blood glucose (BG) and ALT. …”

List of pharmacogenomic drugs, their associated gene(s) and prescriber category. by Emma F. Magavern (20947928)

Subjects:

Percentage of ADR reports for PGx drugs and associated genes by decade. by Emma F. Magavern (20947928)

Subjects:

ADR report numbers and patient demographics stratified by drug PGx status. Sex, age and severity comparison between pharmacogene actionable medicines and non pharmacogene actionabl... by Emma F. Magavern (20947928)

Subjects:

Number and percentage of adverse drug reactions associated with pharmacogenomic drugs stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Study methods and results overview. by Emma F. Magavern (20947928)

Subjects:

Number and percentage of pharmacogenomic mitigatable adverse drug reactions of oestrogen drugs. by Emma F. Magavern (20947928)

Subjects:

Psychiatric pharmacogenomic adverse drug reactions stratified by level of seriousness. by Emma F. Magavern (20947928)

Subjects:

Psychiatric pharmacogenomic drugs stratified by type of adverse drug reaction (cardiac arrhythmia or other) and the level of seriousness. by Emma F. Magavern (20947928)

Subjects:

Number and percenateg of PGx assoicated adverse drug reactions stratified by prescriber category. by Emma F. Magavern (20947928)

Subjects:

UV-B impairs PIF4 binding to shade marker genes’ promoters in a UVR8-dependent manner. by Eleni Tavridou (8822789)

Immune challenge increases the intensity of some Ni-Sp185/333 proteins and decreases the intensity of others. by Lauren S. Sherman (800584)

“…(B) After challenge with <i>V</i>. <i>diazotrophicus</i>, larger MW proteins decrease in intensity (compare white arrows in A and B), whereas the monomers increase in intensity (compare black arrows in A and B).…”

Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19. by Joseph Rabin (7399436)

Subjects: